{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T14:38:50Z","timestamp":1720708730514},"reference-count":78,"publisher":"Oxford University Press (OUP)","issue":"1032","license":[{"start":{"date-parts":[[2011,7,11]],"date-time":"2011-07-11T00:00:00Z","timestamp":1310342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Hypertension is a chronic disorder which often entails debilitating cardiovascular and renal complications. Hypertension mostly arises as a complex quantitative trait that is affected by varying combinations of genetic and environmental factors. Secondary hypertension has been encountered with increasing frequency. The common causes of secondary hypertension include renal parenchymal disease, renal artery stenosis, primary aldosteronism, phaeochromocytoma, and Cushing\u2019s syndrome. The detection of a secondary cause is of the utmost importance because it provides an opportunity to convert an incurable disease into a potentially curable one. Early identification and treatment will provide a better opportunity for cure, prevent target organ damage, reduce socioeconomic burden and health expenditure associated with drug costs, and improve patients' quality of life. Hence, it is a condition not to be missed.<\/jats:p>","DOI":"10.1136\/pgmj.2011.118661","type":"journal-article","created":{"date-parts":[[2011,7,12]],"date-time":"2011-07-12T02:40:52Z","timestamp":1310438452000},"page":"706-713","source":"Crossref","is-referenced-by-count":12,"title":["Secondary hypertension: a condition not to be missed"],"prefix":"10.1093","volume":"87","author":[{"given":"Norlela","family":"Sukor","sequence":"first","affiliation":[{"name":"Endocrine Unit, Department of Medicine, Universiti Kebangsaan Malaysia Medical Centre , Kuala Lumpur, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,7,11]]},"reference":[{"key":"2023041908454939400_b1","first-page":"1","article-title":"Hypertension awareness, treatment, and control\u2014continued disparities in adults: United States, 2005-2006","author":"Ostchega","year":"2008","journal-title":"NCHS Data Brief"},{"key":"2023041908454939400_b2","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.1996.03530440051036","article-title":"Blood pressure as a cardiovascular risk factor: prevention and treatment","volume":"275","author":"Kannel","year":"1996","journal-title":"JAMA"},{"key":"2023041908454939400_b3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/STR.0b013e3181fcb238","article-title":"Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Goldstein","year":"2011","journal-title":"Stroke"},{"key":"2023041908454939400_b4","first-page":"492","article-title":"Hypertension in a family practice","volume":"117","author":"Rudnick","year":"1977","journal-title":"Can Med Assoc J"},{"key":"2023041908454939400_b5","first-page":"S111","article-title":"An appraisal of the genetic approaches to high blood pressure","volume":"14","author":"Harrap","year":"1996","journal-title":"J Hypertens Suppl"},{"key":"2023041908454939400_b6","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, detection, evaluation, and treatment of high blood pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"2023041908454939400_b7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00004872-199405000-00015","article-title":"The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients","volume":"12","author":"Anderson","year":"1994","journal-title":"J Hypertens"},{"key":"2023041908454939400_b8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1291\/hypres.27.193","article-title":"Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan","volume":"27","author":"Omura","year":"2004","journal-title":"Hypertens Res"},{"key":"2023041908454939400_b9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s11906-001-0045-3","article-title":"Primary aldosteronism: rare bird or common cause of secondary hypertension?","volume":"3","author":"Stowasser","year":"2001","journal-title":"Curr Hypertens Rep"},{"key":"2023041908454939400_b10","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumours of the Italian Society of Endocrinology","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041908454939400_b11","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1136\/bmj.298.6688.1626","article-title":"Unrecognised high pressure chronic retention of urine presenting with systemic arterial hypertension","volume":"298","author":"Ghose","year":"1989","journal-title":"BMJ"},{"key":"2023041908454939400_b12","doi-asserted-by":"crossref","first-page":"901","DOI":"10.7326\/0003-4819-145-12-200612190-00143","article-title":"Effectiveness of management strategies for renal artery stenosis: a systematic review","volume":"145","author":"Balk","year":"2006","journal-title":"Ann Intern Med"},{"key":"2023041908454939400_b13","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"key":"2023041908454939400_b14","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","article-title":"ACC\/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery\/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC\/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"key":"2023041908454939400_b15","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1161\/CIRCULATIONAHA.106.178777","article-title":"Indications for renal arteriography at the time of coronary arteriography: a science advisory from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Councils on Cardiovascular Radiology and Intervention and on Kidney in Cardiovascular Disease","volume":"114","author":"White","year":"2006","journal-title":"Circulation"},{"key":"2023041908454939400_b16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJM200102083440607","article-title":"Renal-artery stenosis","volume":"344","author":"Safian","year":"2001","journal-title":"N Engl J Med"},{"key":"2023041908454939400_b17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.7326\/0003-4819-135-6-200109180-00009","article-title":"Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis","volume":"135","author":"Vasbinder","year":"2001","journal-title":"Ann Intern Med"},{"key":"2023041908454939400_b18","first-page":"228","article-title":"Ultrasound as a first line screening tool for the detection of renal artery stenosis: a comprehensive review","volume":"12","author":"Spyridopoulos","year":"2010","journal-title":"Med Ultrason"},{"key":"2023041908454939400_b19","doi-asserted-by":"crossref","first-page":"730","DOI":"10.7326\/0003-4819-141-9-200411020-00017","article-title":"Pitfalls in imaging for renal artery stenosis","volume":"141","author":"Textor","year":"2004","journal-title":"Ann Intern Med"},{"key":"2023041908454939400_b20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/0003-4819-141-9-200411020-00007","article-title":"Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis","volume":"141","author":"Vasbinder","year":"2004","journal-title":"Ann Intern Med"},{"key":"2023041908454939400_b21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0140-6736(98)04432-8","article-title":"Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial","volume":"353","author":"van de Ven","year":"1999","journal-title":"Lancet"},{"key":"2023041908454939400_b22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/01.CIR.0000153271.77341.9F","article-title":"Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis","volume":"111","author":"Silva","year":"2005","journal-title":"Circulation"},{"key":"2023041908454939400_b23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/HYPERTENSIONAHA.110.152918","article-title":"Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: A systematic review and meta-analysis","volume":"56","author":"Trinquart","year":"2010","journal-title":"Hypertension"},{"key":"2023041908454939400_b24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.semvascsurg.2010.05.004","article-title":"Randomized clinical trials regarding management of atherosclerotic renovascular disease","volume":"23","author":"Fleming","year":"2010","journal-title":"Semin Vasc Surg"},{"key":"2023041908454939400_b25","first-page":"1863","article-title":"Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology","volume":"85","author":"Fardella","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041908454939400_b26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2023041908454939400_b27","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/jama.1977.03270400035014","article-title":"Diagnosis of secondary forms of hypertension. A comprehensive protocol","volume":"237","author":"Grim","year":"1977","journal-title":"JAMA"},{"key":"2023041908454939400_b28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.jhh.1001013","article-title":"High prevalence of primary aldosteronism in the Tayside hypertension clinic population","volume":"14","author":"Lim","year":"2000","journal-title":"J Hum Hypertens"},{"key":"2023041908454939400_b29","first-page":"2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore","volume":"85","author":"Loh","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041908454939400_b30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"2023041908454939400_b31","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2023041908454939400_b32","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041908454939400_b33","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2023041908454939400_b34","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","article-title":"Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism","volume":"40","author":"Mulatero","year":"2002","journal-title":"Hypertension"},{"key":"2023041908454939400_b35","first-page":"457","article-title":"Effects of nifedipine treatment on the renin-angiotensin-aldosterone axis","volume":"82","author":"Fiad","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041908454939400_b36","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03349761","article-title":"Primary aldosteronism","volume":"18","author":"Gordon","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"2023041908454939400_b37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/eje.0.1500329","article-title":"Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication","volume":"150","author":"Seiler","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"2023041908454939400_b38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3317\/jraas.2001.022","article-title":"Diagnosis and management of primary aldosteronism","volume":"2","author":"Stowasser","year":"2001","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2023041908454939400_b39","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2003-0279","article-title":"Minireview: primary aldosteronism\u2014changing concepts in diagnosis and treatment","volume":"144","author":"Young","year":"2003","journal-title":"Endocrinology"},{"key":"2023041908454939400_b40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mce.2003.10.006","article-title":"Primary aldosteronism\u2014careful investigation is essential and rewarding","volume":"217","author":"Stowasser","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"2023041908454939400_b41","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1521-690X(03)00050-2","article-title":"Primary aldosteronism","volume":"17","author":"Stowasser","year":"2003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2023041908454939400_b42","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1097\/HJH.0b013e3283060f0c","article-title":"Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma","volume":"26","author":"Letavernier","year":"2008","journal-title":"J Hypertens"},{"key":"2023041908454939400_b43","first-page":"447","article-title":"Primary aldosteronism\u2014part I: prevalence, screening, and selection of cases for adrenal vein sampling","volume":"21","author":"Rossi","year":"2008","journal-title":"J Nephrol"},{"key":"2023041908454939400_b44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00019616-199707040-00003","article-title":"Primary aldosteronism: update on diagnosis and treatment","volume":"7","author":"Young","year":"1997","journal-title":"Endocrinologist"},{"key":"2023041908454939400_b45","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00268-001-0033-4","article-title":"Primary aldosteronism: are we diagnosing and operating on too few patients?","volume":"25","author":"Gordon","year":"2001","journal-title":"World J Surg"},{"key":"2023041908454939400_b46","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archsurg.141.5.497","article-title":"Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome","volume":"141","author":"Nwariaku","year":"2006","journal-title":"Arch Surg"},{"key":"2023041908454939400_b47","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism","volume":"136","author":"Young","year":"2004","journal-title":"Surgery"},{"key":"2023041908454939400_b48","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1148\/radiology.186.3.8430178","article-title":"Adrenal masses: differentiation with chemical shift, fast low-angle shot MR imaging","volume":"186","author":"Tsushima","year":"1993","journal-title":"Radiology"},{"key":"2023041908454939400_b49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1210\/jcem-45-2-353","article-title":"A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans","volume":"45","author":"Sarkar","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041908454939400_b50","first-page":"7","article-title":"Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism","volume":"20","author":"Freitas","year":"1979","journal-title":"J Nucl Med"},{"key":"2023041908454939400_b51","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00006231-200306000-00011","article-title":"Non-invasive adrenal imaging in primary aldosteronism. Sensitivity and positive predictive value of radiocholesterol scintigraphy, CT scan and MRI","volume":"24","author":"Lumachi","year":"2003","journal-title":"Nucl Med Commun"},{"key":"2023041908454939400_b52","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM197602192940802","article-title":"Location of aldosterone-producing adenomas with 131I-19-iodocholesterol","volume":"294","author":"Hogan","year":"1976","journal-title":"N Engl J Med"},{"key":"2023041908454939400_b53","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1210\/jcem-71-4-825","article-title":"Iodomethylnorcholesterol uptake in an aldosteronoma shown by dexamethasone-suppression scintigraphy: relationship to adenoma size and functional activity","volume":"71","author":"Nomura","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041908454939400_b54","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00004872-200311000-00025","article-title":"High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients","volume":"21","author":"Stowasser","year":"2003","journal-title":"J Hypertens"},{"key":"2023041908454939400_b55","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s002689900552","article-title":"Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production","volume":"22","author":"Rutherford","year":"1998","journal-title":"World J Surg"},{"key":"2023041908454939400_b56","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2009-1763","article-title":"Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism","volume":"95","author":"Sukor","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041908454939400_b57","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet"},{"key":"2023041908454939400_b58","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2005-1862","article-title":"Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes","volume":"91","author":"Benn","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041908454939400_b59","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJMoa020152","article-title":"Germ-line mutations in nonsyndromic pheochromocytoma","volume":"346","author":"Neumann","year":"2002","journal-title":"N Engl J Med"},{"key":"2023041908454939400_b60","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJM199906173402404","article-title":"Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2","volume":"340","author":"Eisenhofer","year":"1999","journal-title":"N Engl J Med"},{"key":"2023041908454939400_b61","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1210\/jc.2002-021251","article-title":"A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines","volume":"88","author":"Sawka","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041908454939400_b62","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","article-title":"Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results","volume":"88","author":"Eisenhofer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041908454939400_b63","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1210\/er.2003-0032","article-title":"Functional imaging of endocrine tumors: role of positron emission tomography","volume":"25","author":"Pacak","year":"2004","journal-title":"Endocr Rev"},{"key":"2023041908454939400_b64","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2265.2008.03256.x","article-title":"123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation","volume":"69","author":"Bhatia","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023041908454939400_b65","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00006231-200607000-00006","article-title":"Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas: a prospective study","volume":"27","author":"Lumachi","year":"2006","journal-title":"Nucl Med Commun"},{"key":"2023041908454939400_b66","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1210\/jc.2003-030235","article-title":"Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma","volume":"88","author":"Ilias","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041908454939400_b67","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1200\/JCO.2006.09.6297","article-title":"Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma","volume":"25","author":"Timmers","year":"2007","journal-title":"J Clin Oncol"},{"key":"2023041908454939400_b68","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2796.1993.tb01018.x","article-title":"Response of hypertension to conventional antihypertensive treatment and\/or steroidogenesis inhibitors in Cushing\u2019s syndrome","volume":"234","author":"Fallo","year":"1993","journal-title":"J Intern Med"},{"key":"2023041908454939400_b69","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0140-6736(82)92749-0","article-title":"Cushing\u2019s syndrome\u2014killing disease: discriminatory value of signs and symptoms aiding early diagnosis","volume":"2","author":"Ross","year":"1982","journal-title":"Lancet"},{"key":"2023041908454939400_b70","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041908454939400_b71","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1210\/jc.2004-2264","article-title":"Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test","volume":"90","author":"Viardot","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041908454939400_b72","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1210\/jc.2003-031790","article-title":"Midnight salivary cortisol for the initial diagnosis of Cushing\u2019s syndrome of various causes","volume":"89","author":"Yaneva","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041908454939400_b73","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/000456329703400302","article-title":"Evidence for the low dose dexamethasone suppression test to screen for Cushing\u2019s syndrome\u2014recommendations for a protocol for biochemistry laboratories","volume":"34","author":"Wood","year":"1997","journal-title":"Ann Clin Biochem"},{"key":"2023041908454939400_b74","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1210\/jc.2007-1289","article-title":"Editorial: The dexamethasone-suppressed corticotropin-releasing hormone test for the diagnosis of Cushing\u2019s syndrome: what have we learned in 14 years?","volume":"92","author":"Nieman","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041908454939400_b75","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1210\/jc.2006-2829","article-title":"Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild cushing\u2019s disease from pseudo-Cushing\u2019s syndrome","volume":"92","author":"Gatta","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041908454939400_b76","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3171\/JNS\/2008\/108\/01\/0009","article-title":"Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years","volume":"108","author":"Hofmann","year":"2008","journal-title":"J Neurosurg"},{"key":"2023041908454939400_b77","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJMc1000094","article-title":"Pasireotide alone or with cabergoline and ketoconazole in Cushing\u2019s disease","volume":"362","author":"Feelders","year":"2010","journal-title":"N Engl J Med"},{"key":"2023041908454939400_b78","first-page":"117","article-title":"Incidence and late prognosis of Cushing\u2019s syndrome: a population-based study","volume":"86","author":"Lindholm","year":"2001","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/87\/1032\/706\/50019509\/postgradmedj-87-706.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/87\/1032\/706\/50019509\/postgradmedj-87-706.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T09:00:50Z","timestamp":1681894850000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/87\/1032\/706\/7032009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,11]]},"references-count":78,"journal-issue":{"issue":"1032","published-online":{"date-parts":[[2011,7,11]]},"published-print":{"date-parts":[[2011,10,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.2011.118661","relation":{},"ISSN":["1469-0756","0032-5473"],"issn-type":[{"value":"1469-0756","type":"electronic"},{"value":"0032-5473","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,10]]},"published":{"date-parts":[[2011,7,11]]}}}